Compass Group(CMPGY)

Search documents
Compass Minerals: A Risky But Interesting Prospect As Shares Surge
Seeking Alpha· 2024-09-18 02:09
September 17th ended up being a really good day for shareholders of Compass Minerals International (NYSE: CMP ). Shares of the company spiked, rising by 21.1% for the day, after management announced preliminary Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential. Subscribers get to use a 50+ stock model account, in-depth cash flow analyses of E&P ...
Is Compass Group (CMPGY) Outperforming Other Retail-Wholesale Stocks This Year?
ZACKS· 2024-09-12 14:46
Investors interested in Retail-Wholesale stocks should always be looking to find the best-performing companies in the group. Is Compass Group PLC (CMPGY) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Retail-Wholesale sector should help us answer this question. Compass Group PLC is a member of the Retail-Wholesale sector. This group includes 211 individual stocks and currently holds a Zacks Sector Rank of #9. The Zacks Sector Rank con ...
All You Need to Know About Compass Group (CMPGY) Rating Upgrade to Buy
ZACKS· 2024-09-11 17:00
Core Viewpoint - Compass Group PLC (CMPGY) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are crucial for predicting near-term stock price movements [2][4]. - The recent upgrade reflects an improvement in Compass Group's earnings outlook, likely leading to increased buying pressure and a rise in stock price [3][5]. Earnings Estimate Revisions - Compass Group is projected to earn $1.20 per share for the fiscal year ending September 2024, representing a year-over-year increase of 13.2% [8]. - Over the past three months, the Zacks Consensus Estimate for Compass Group has risen by 0.8%, indicating a positive trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - The upgrade to Zacks Rank 2 places Compass Group in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].
Compass CEO & Founder Robert Reffkin to Speak at Zelman Housing Summit
Prnewswire· 2024-09-04 20:30
Company Overview - Compass, Inc. is the largest residential real estate brokerage in the United States by sales volume, founded in 2012 and based in New York City [3][4] - The company provides an end-to-end platform that empowers residential real estate agents with cloud-based software for various functionalities including customer relationship management, marketing, and brokerage services [3] Upcoming Event - CEO and Founder Robert Reffkin will speak at the Zelman Housing Summit on September 12, 2024, at the InterContinental Hotel in Boston [1] - The interview will be available via a public webcast and can be replayed on the Compass Investor Relations website [2]
Toronto Hospitality Experts The Food Dudes Announce Exclusive Partnership with Nation's Leading Food Service Provider, Compass Group Canada
GlobeNewswire News Room· 2024-09-03 12:45
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Food Dudes, Toronto's renowned culinary firm founded by Chef Adrian Niman, announced today an exclusive partnership with Compass Group Canada, the country's leading food service and support services provider. This alliance marks a major milestone that sees The Food Dudes fusing the cutting-edge style of their distinctive products with Compass Group Canada's expansive operational capabilities and industry expertise. Founded in 2009, The Food Dudes are best know ...
Compass Therapeutics to Participate in Upcoming Investor Events
GlobeNewswire News Room· 2024-09-03 12:00
Company Overview - Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases [2] - The company was founded in 2014 and is headquartered in Boston, Massachusetts [2] - Compass's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth [2] Product Pipeline - The company is developing a pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective antitumor response [2] - Key strategies include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance [2] - Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data [2] Upcoming Investor Events - Compass Therapeutics will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 11:00am ET in New York, NY [1] - The company will also attend the Cantor Global Healthcare Conference on September 17, 2024, at 8:35am ET, also in New York, NY [1] - Presentations from these events will be archived for 90 days on Compass's Events page [1]
Compass Pathways to participate in three investor conferences in September
GlobeNewswire News Room· 2024-08-28 10:00
Group 1 - Compass Pathways plc is a biotechnology company focused on mental health innovation, particularly through its proprietary psilocybin treatment, COMP360, which has received Breakthrough Therapy designation from the FDA and ILAP designation in the UK for treatment-resistant depression [2][3] - The company has initiated a phase 3 clinical program for COMP360 psilocybin treatment in treatment-resistant depression, marking it as the largest randomized, controlled, double-blind psilocybin treatment clinical program ever conducted [3] - Previous studies, including a phase 2b study, demonstrated a statistically significant improvement in depressive symptom severity after three weeks for patients receiving a single 25mg dose of COMP360 with psychological support [3] Group 2 - Compass Pathways will participate in several investor conferences in September 2024, including the Morgan Stanley 22nd Annual Global Healthcare Conference, H. C. Wainwright 26th Annual Global Investment Conference, and Cantor Global Healthcare Conference, with live audio webcasts available [1] - The company is headquartered in London, UK, with additional offices in New York and San Francisco, and aims to promote mental wellbeing globally [4]
Compass: Amid Market Share Gains And NAR Ruling Confidence, This Stock Is A Buy
Seeking Alpha· 2024-08-27 22:20
THE HO F E I 11 # Justin Paget The whole market is volatile right now, but one industry that is going through tremendous changes on multiple fronts is the real estate industry. Despite the potential benefit from declining interest rate expectations (mortgage rates have been dropping over the past few weeks, owing in large part to expectations of Fed rate cuts amid a possible U.S. recession), the industry is still watching and waiting to see what will happen once new rules from the NAR lawsuit settlement, al ...
Compass Diversified Announces Stephen Keller as Chief Financial Officer
GlobeNewswire News Room· 2024-08-26 10:00
WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to fac ...
Compass Diversified-Backed Altor Solutions to Acquire Lifoam Industries
GlobeNewswire News Room· 2024-08-19 12:00
WESTPORT, Conn., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Altor Solutions ("Altor"), a subsidiary of Compass Diversified (NYSE: CODI) and a leading designer and manufacturer of custom protective and coldchain packaging solutions for the industrial and life sciences markets, today announced it has entered into a definitive agreement to acquire Lifoam Industries, LLC ("Lifoam"), a manufacturer and distributor of temperature-controlled shipping solutions, for an enterprise value of $137 million in cash at closing (ex ...